Dodávka real-time PCR reagencií - část 3 - Cytomegalovirus (CMV), Herpes Simplex Virus 1 (HSV-1), Herpes Simplex Virus 2 (HSV-2), Varicella-Zoster Virus (VZV), Treponema pallidum
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1137/2022-SML-01 | 05. 12. 2023 | Biolife s.r.o. | 162 043,20 | 133 920,00 | 162 043,20 | 133 920,00 | CZK | |
| D01409/2022 | 18. 07. 2022 | Biolife s.r.o. | 324 086,40 | 267 840,00 | 324 086,40 | 267 840,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| Písemná zpráva - část 3 signed 02082022.pdf | Písemná zpráva zadavatele | 02. 08. 2022 13:29 | Dokument není zavirovaný |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| Biolife s.r.o. | Praha | |||||
| GeneProof a.s. | Brno |
Price Actually Paid in Each Year of Performance
| D01409/2022 | 2023 | 268 692,60 | 222 060,00 |
| D01409/2022 | 2022 | 96 993,60 | 80 160,00 |